Case Reports in Medicine analyzed and interpreted the patient’s medical and exposure data regarding the diagnosis of Goodpasture’s Syndrome. J. Dahlgren, T. Peckham, and M. Wardenburg reviewed and summarized relevant literature and were major contributors in the writing of the manuscript. All authors read and approved the ﬁnal manuscript. Acknowledgment The authors thank Maria Dominguez, Alex Lee, Elisabeth Choi, and Jason Klein for their comments and help in revising the manuscript. References [1] National Institute for Occupational Safety and Health (NIOSH), “Health eﬀects of occupational exposure to res- pirable crystalline Silica,” NIOSH Hazard Review, 2002. [2] M. C. Stanton and J. D. Tange, “Goodpasture’s syndrome (pulmonary hemorrhage associated with glomerulonephri- tis),” Australasian Annals of Medicine, vol. 7, pp. 132–134, 1958. [3] M. G. Kim, D. H. Koh, S. W. Lee, M. H. Jo, H. Y. Yoo, and J. H. Lee, “A case of Goodpasture’s syndrome in a foundry worker,” Korean Journal of Occupational Environmental Medicine, vol. 20, no. 1, pp. 46–53, 2008. [4] A. P. Garc´ıa, J. P. Sandoval, L. M. Abad, J. G. Mart´ınez, and J. M. C. Rodr´ıguez, “Goodpasture’s syndrome: 2 new cases. Possible role of some substances in its development,” Revista Clinica Espanola, vol. 156, no. 3, pp. 203–206, 1980. [5] F. B. Michel, P. Baldet, and C. Touron, “Goodpasture’s syndrome and pneumoconiosis (2 cases),” Le Poumon et le Coeur, vol. 29, no. 3, pp. 305–309, 1973. [6] G. J. Bombassei and A. A. Kaplan, “The association between hydrocarbon exposure and anti-glomerular basement mem- brane antibody-mediated disease (Goodpasture’s syndrome),” American Journal of Industrial Medicine, vol. 21, no. 2, pp. 141– 153, 1992. [7] M. K. Shah, “Outcomes in patients with Goodpasture’s Syndrome and hydrocarbon exposure,” Renal Failure, vol. 24, no. 5, pp. 545–555, 2002. [8] R. Peces, R. A. Navascue´s, J. Baltar, M. Seco, and J. Alvarez, “Antiglomerular basement membrane antibody- mediated glomerulonephritis after intranasal cocaine use,” Nephron, vol. 81, no. 4, pp. 434–438, 1999. [9] P. Lechleitner, M. Defregger, K. Lhotta, M. To¨tsch, and F. Fend, “Goodpasture’s syndrome: unusual presentation after exposure to hard metal dust,” Chest, vol. 103, no. 3, pp. 956– 957, 1993. [10] C. T. Derk and S. A. Jimenez, “Goodpasture-like syndrome induced by D-penicillamine in a patient with systemic scle- rosis: report and review of the literature,” The Journal of Rheumatology, vol. 30, no. 7, pp. 1616–1620, 2003. [11] American Conference of Governmental Industrial Hygien- ists (ACGIH), “Silica, crystalline: quartz and cristobalite,” Threshold limit values for chemical substances and physical agents. Biological exposure indices, Cincinnati, OH, American Conference of Governmental Industrial Hygienists, 2006. [12] National Institute for Occupational Safety and Health (NIOSH), “Silica, crystalline (as respirable dust),” NIOSH pocket guide to chemical hazards. Atlanta, GA: National 5 Institute for Occupational Safety and Health, Centers for Dis- ease Control and Prevention, 2005, http://www.cdc.gov/niosh/ npg/npgd0684.html. [13] J. M. Brown, J. C. Pfau, M. A. Pershouse, and A. Holian, “Silica, apoptosis, and autoimmunity,” Journal of Immunotoxicology, vol. 1, no. 3, pp. 177–187, 2004. [14] G. S. Cooper, F. W. Miller, and D. R. Germolec, “Occu- pational exposures and autoimmune diseases,” International Immunopharmacology, vol. 2, no. 2-3, pp. 303–313, 2002. [15] C. G. Parks, K. Conrad, and G. S. Cooper, “Occupational exposure to crystalline Silica and autoimmune disease,” Envi- ronmental Health Perspectives, vol. 107, supplement 5, pp. 793– 802, 1999. [16] J. Sanchez-Roman, I. Wichmann, J. Salaberri, J. M. Varela, and A. Nunez-Roldan, “Multiple clinical and biological autoimmune manifestations in 50 workers after occupational exposure to Silica,” Annals of the Rheumatic Diseases, vol. 52, no. 7, pp. 534–538, 1993. [17] U.-F. Haustein, V. Ziegler, K. Herrmann, J. Mehlhorn, and C. Schmidt, “Silica-induced scleroderma,” Journal of the American Academy of Dermatology, vol. 22, no. 3, pp. 444–448, 1990. [18] K. Steenland, S. Nowlin, B. Ryan, and S. Adams, “Use of multiple-cause mortality data in epidemiologic analyses: US rate and proportion ﬁles developed by the National Institute for Occupational Safety and Health and the National Cancer Institute,” American Journal of Epidemiology, vol. 136, no. 7, pp. 855–862, 1992. [19] G. K. Sluis-Cremer, P. A. Hessel, E. Hnizdo, and A. R. Churchill, “Relationship between silicosis and rheumatoid arthritis,” Thorax, vol. 41, no. 8, pp. 596–601, 1986. [20] V. Rafnsson, O. Ingimarsson, I. Hjalmarsson, and H. Gunnars- dottir, “Association between exposure to crystalline Silica and risk of sarcoidosis,” Occupational and Environmental Medicine, vol. 55, no. 10, pp. 657–660, 1998. [21] K. Steenland and D. F. Goldsmith, “Silica exposure and autoimmune diseases,” American Journal of Industrial Medicine, vol. 28, no. 5, pp. 603–608, 1995. [22] G. Gregorini, P. Tira, J. Frizza et al., “ANCA-associated diseases and Silica exposure,” Clinical Reviews in Allergy and Immunology, vol. 15, no. 1, pp. 21–40, 1997. [23] G. M. Calvert, K. Steenland, and S. Palu, “End-stage renal disease among Silica-exposed gold miners: a new method for assessing incidence among epidemiologic cohorts,” Journal of the American Medical Association, vol. 277, no. 15, pp. 1219– 1223, 1997. [24] N. K. Steenland, M. J. Thun, C. W. Ferguson, and F. K. Port, “Occupational and other exposures associated with male end- stage renal disease: a case/control study,” American Journal of Public Health, vol. 80, no. 2, pp. 153–157, 1990. [25] S. L. Hogan, K. K. Satterly, M. A. Dooley, P. H. Nachman, J. C. Jennette, and R. J. Falk, “Silica exposure in anti-neutrophil cytoplasmic autoantibody-associated glomerulonephritis and Lupus nephritis,” Journal of the American Society of Nephrol- ogy, vol. 12, no. 1, pp. 134–142, 2001. [26] S. Fenwick and J. Main, “Increased prevalence of renal disease in Silica-exposed workers,” The Lancet, vol. 356, no. 9233, pp. 913–914, 2000. [27] K. Steenland, W. Sanderson, and G. M. Calvert, “Kidney disease and arthritis in a cohort study of workers exposed to Silica,” Epidemiology, vol. 12, no. 4, pp. 405–412, 2001. [28] T. P. Ng, H. S. Lee, and W. H. Phoon, “Further evidence of human Silica nephrotoxicity in occupationally exposed